Misoprostol FDA Link Generic

A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.

Also Known As:

Cytotec; Apo-Misoprostol; Glefos; Misoprostol, (11alpha,13E)-Isomer; Misoprostol, (11alpha,13E,16R)-Isomer; Misoprostol, (11alpha,13Z)-(+-)-Isomer; Misoprostol, (11alpha.13E,16S)-Isomer; Misoprostol, (11beta,13E)-(+-)-Isomer; Misoprostol, (11beta,13E,16R)-Isomer; Misoprostol, (11beta,13E,16S)-Isomer; Novo-Misoprostol; SC-29333; SC-30249; Apo Misoprostol; Novo Misoprostol; SC 29333; SC 30249; SC29333; SC30249; Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-

Pharmalogical Action Categories:

Abortifacient Agents, Nonsteroidal
Anti-Ulcer Agents
Oxytocics

Lipids: 118169
- Fatty Acids: 28212
  - Unsaturated Fatty Acids: 8458
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Synthetic Prostaglandins: 835
        Synthetic Prostaglandins E: 6
        Misoprostol: 2182
Biological Factors: 2560
- Inflammation Mediators: 1126
  - Synthetic Prostaglandins: 835
    - Synthetic Prostaglandins E: 6
      - Misoprostol: 2182
  - Autacoids: 278
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Synthetic Prostaglandins: 835
        Synthetic Prostaglandins E: 6
        Misoprostol: 2182

H Kagoro Selected Research

H Kagoro Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure